Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.20). Revenue for the quarter came in at $166.45 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• JPMorgan Reiterates Overweight Rating on Dixon Technologies India Ltd (DIXON:IN)
• Reddit (RDDT) Reiterated at Market Outperform by Citizens Amid SEO Volatility
• Kura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results